Sökning: WFRF:(Vellas Bruno) >
What Drives Country...
What Drives Country Differences in Cost of Alzheimer's Disease? : An Explanation from Resource Use in the GERAS Study
-
- Reed, Catherine (författare)
- Eli Lilly & Co Ltd, Lilly Res Ctr, Windlesham, Surrey, England.
-
- Happich, Michael (författare)
- Lilly Deutschland GmbH, Bad Homburg, Germany.
-
- Maria Argimon, Josep (författare)
- Serv Catala Salut, Div Avaluacio, Barcelona, Spain.
-
visa fler...
-
- Maria Haro, Josep (författare)
- Univ Barcelona, CIBERSAM, Parc Santari St Joan de Deu, Barcelona, Spain.
-
- Wimo, Anders (författare)
- Karolinska Institutet,Uppsala universitet,Centrum för klinisk forskning, Gävleborg,Karolinska Inst, KI Div Neurogeriatr, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.
-
- Bruno, Giuseppe (författare)
- Univ Rome Sapienza, Dept Neurol & Psychiat, Clin Memoria, Rome, Italy.
-
- Dodel, Richard (författare)
- Philipps Univ, Dept Neurol, Marburg, Germany.
-
- Jones, Roy W. (författare)
- Royal United Hosp, RICE Ctr, RICE Res Inst Care Older People, Bath, Avon, England.
-
- Vellas, Bruno (författare)
- Toulouse Univ, INSERM 1027, Alzheimers Dis Res & Clin Care, Gerontopole, Toulouse, France.
-
- Belger, Mark (författare)
- Eli Lilly & Co Ltd, Lilly Res Ctr, Windlesham, Surrey, England.
-
visa färre...
-
Eli Lilly & Co Ltd, Lilly Res Ctr, Windlesham, Surrey, England Lilly Deutschland GmbH, Bad Homburg, Germany. (creator_code:org_t)
- IOS PRESS, 2017
- 2017
- Engelska.
-
Ingår i: Journal of Alzheimer's Disease. - : IOS PRESS. - 1387-2877 .- 1875-8908. ; 57:3, s. 797-812
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.3...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- Background: Country differences in resource use and costs of Alzheimer's disease (AD) may be driven by differences in health care systems and resource availability. Objective: To compare country resource utilization drivers of societal costs for AD dementia over 18 months. Methods: GERAS is an observational study in France (n = 419), Germany (n = 550), and the UK (n = 526). Resource use of AD patients and caregivers contributing to >1% of total societal costs (year 2010) was assessed for country differences, adjusting for participant characteristics. Results: Mean 18-month societal costs per patient were France (sic)33,339, Germany (sic)38,197, and UK (sic)37,899 (32,501) pound. Caregiver time spent on basic and instrumental activities of daily living (ADL) contributed the most to societal costs (54% France, 64% Germany, 65% UK). Caregivers in France spent less time on ADL than UK caregivers and missed fewer work days than in other countries. Compared with other countries, patients in France used more community care services overall and were more likely to use home aid. Patients in Germany were least likely to use temporary accommodation or to be institutionalized at 18 months. UK caregivers spent the most time on instrumental ADL, UK patients used fewest outpatient resources, and UK patients/caregivers were most likely to receive financial support. Conclusion: Caregiver time on ADL contributed the most to societal costs and differed across countries, possibly due to use of community care services and institutionalization. Other resources had different patterns of use across countries, reflecting country-specific health and social care systems.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Neurologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Neurology (hsv//eng)
Nyckelord
- Activities of daily living
- Alzheimer's disease
- caregivers
- costs
- health resources
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Reed, Catherine
-
Happich, Michael
-
Maria Argimon, J ...
-
Maria Haro, Jose ...
-
Wimo, Anders
-
Bruno, Giuseppe
-
visa fler...
-
Dodel, Richard
-
Jones, Roy W.
-
Vellas, Bruno
-
Belger, Mark
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Neurologi
- Artiklar i publikationen
-
Journal of Alzhe ...
- Av lärosätet
-
Uppsala universitet
-
Karolinska Institutet